Skip to content
Live news Screener Coverage Pricing Docs REST API WebSocket API MCP server Company Use cases Blog Changelog Status Compare Contact
BIVI$1.24-0.04(-3.13%)From Private Credit to Fusion Power: New to The Street Show #777 Premieres Tonight on Bloomberg Television[10:30:00 AM ET]AMGN$439.26-8.02(-1.79%)IMDELLTRA® IN COMBINATION WITH IMFINZI® REDUCED RISK OF DEATH BY AN UNPRECEDENTED 58% IN FIRST-LINE EXTENSIVE STAGE SMALL CELL LUNG CANCER Amgen (NASDAQ:AMGN) today announced landmark interim Phase 3 results showing that IMDELLTRA® (tarlatamab-dlle) in combination with AstraZeneca's...[10:30:00 AM ET]JNJ$263.81-3.80(-1.42%)Johnson & Johnson announces ERLEADA® (apalutamide) treatment before and after surgery reduces risk of recurrence or death by 62% versus surgery alone in high-risk prostate cancer Johnson & Johnson (NYSE: JNJ) today announced new results from the Phase 3 PROTEUS substudy that directly compared the investigational use of...[8:54:00 AM ET]PBLS$24.79-2.13(-7.91%)Parabilis Medicines Presents Updated Phase 1/2 Data for Zolucatetide Demonstrating Compelling Efficacy and Favorable Safety and Tolerability Profile in Patients with Desmoid Tumors[8:45:00 AM ET]SMTC$131.80+6.68(+5.34%)Semtech Brings 5G Network Slicing, FIPS 140-3 to IACP 2026[8:00:00 AM ET]GMAB$43.85+3.85(+9.63%)Genmab and Incyte Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]INCY$115.00-1.93(-1.65%)Incyte and Genmab Announce Clinical Trial Collaboration in Metastatic Colorectal Cancer[7:00:00 AM ET]NBTX$29.36+0.17(+0.58%)NANOBIOTIX Announces Final Data from Phase 1 Study Evaluating JNJ-1900 (NBTXR3) With Immune Checkpoint Inhibitors as a 2L+ Therapy in Anti-PD-1-Resistant Primary Cutaneous Melanoma[7:00:00 AM ET]ONC$377.63-4.64(-1.21%)BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 2026[4:15:00 AM ET]CMPX$0.77-0.03(-3.97%)Compass Therapeutics Announces Publication of Phase 2/3 COMPANION-002 Results for Tovecimig in the Journal of Clinical Oncology and Oral Presentation at ESMO 2026[4:15:00 AM ET]CELC$63.20-2.37(-3.61%)Celcuity Presents Updated Results from the PIK3CA MT Cohort of the Phase 3 VIKTORIA-1 Study in Patients with HR+/HER2- Advanced Breast Cancer at the ESMO Congress 2026[4:15:00 AM ET]ZYME$28.22-0.22(-0.77%)Zymeworks Presents New Phase 1 Data for Folate Receptor Alpha-Targeting Antibody-Drug Conjugate ZW191 at ESMO Congress 2026[2:30:00 AM ET]

SYF · NYSE

Synchrony Financial

$73.64 -1.26 (-1.68%)

Company overview

Synchrony Financial, together with its subsidiaries, operates as a consumer financial services company in the United States. It provides credit products such as credit cards, commercial credit products, and consumer installment loans. The company also offers private label credit cards, dual cards, co-brand and general purpose credit cards, short- and long-term installment loans, and consumer banking products; and deposit products, including certificates of deposit, individual retirement accounts, money market accounts, and savings accounts to retail and commercial customers, as well as accepts deposits through third-party securities brokerage firms.

Sector
Financial Services
Industry
Financial - Credit Services
Exchange
NYSE
Market cap
$24B
Employees
20,000
Headquarters
Stamford, CT
CEO
Brian D. Doubles
Listed
July 31, 2014
P/E
7.55
Dividend yield
1.56%

Company financials

Revenue
$19.9B
Gross profit
$12.2B
Operating income
$4.6B
EBITDA
$4.9B
Net income
$3.6B
EPS
$9.76
Total assets
$122B
Total debt
$16.4B
Gross margin
61.08%
Net margin
18.08%
Earnings yield
13.25%

Price chart

67.5071.2474.9978.7382.47
SYF 1D NYSE O73.77H74.37L73.14C73.83-1.26 (-1.68%)Vol1.27M

News

15-min delaySigned-out view is delayed 15 minutes. Log in on Pro for the live news desk.

Source
Date
Type
Ticker Type Headline Source Published
SYF Stock news Macro Concerns Grow, But Synchrony's Earnings Remain Resilient Seeking Alpha
SYF Stock news Why Synchrony (SYF) is a Top Value Stock for the Long-Term Zacks Investment Research
SYF Stock news Synchrony (SYF) Upgraded to Buy: What Does It Mean for the Stock? Zacks Investment Research
SYF Stock news SYF or FUTU: Which Is the Better Value Stock Right Now? Zacks Investment Research
SYF Stock news Should Value Investors Buy Synchrony Financial (SYF) Stock? Zacks Investment Research
SYF Press release With a Fed Decision a Week Away, Lenders Show How Borrowers Are Handling Higher Rates The Federal Reserve's next interest rate decision is one week away, and the record of its last meeting shows where most officials were leaning.... PR Newswire
SYF Press release CareCredit Introduces CareCredit Pay Later, Offering Consumers Another Way to Plan and Pay for Health and Wellness Care CareCredit, a Synchrony (NYSE: SYF) solution, today launched CareCredit Pay Later, its enhanced and rebranded installmen. PR Newswire
SYF Press release Synchrony Reports Third Quarter 2026 Results Synchrony Financial (NYSE: SYF) today announced its third quarter 2026 results for the period ending September 30, 2026. The earnings news release... PR Newswire
SYF Stock news Countdown to Synchrony (SYF) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS Zacks Investment Research
SYF Stock news Synchrony Financial Likely To Report Lower Q3 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call Benzinga
SYF Stock news Can Higher Purchase Volumes Lift Synchrony Financial's Q3 Earnings? Zacks Investment Research
SYF Stock news Is the Options Market Predicting a Spike in Synchrony Financial Stock? Zacks Investment Research
SYF Stock news Synchrony (SYF) Expected to Beat Earnings Estimates: Should You Buy? Zacks Investment Research
SYF Press release Weave and CareCredit Go Live with Integration That Places Patient Financing Inside the Front-Office Workflow Business Wire
SYF Stock news Upstart Jumps 6% as Its Own Macro Index Ticks Down; Synchrony Financial Holds Flat, OneMain Holdings Barely Budges 24/7 Wall Street
SYF Stock news Synchrony Financial (NYSE:SYF) Stock Sees Heavy Call Option Buying Defense World
SYF Stock news Synchrony Deepens CareCredit's Veterinary Reach With Vetspire Tie-Up Zacks Investment Research
SYF Stock news How Can Trust Shape Synchrony Financial's AI Shopping Opportunity? Zacks Investment Research
SYF Press release CareCredit Partners with Vetspire to Modernize Veterinary Payments with AI-Enabled Practice Solutions PRNewsWire
SYF Press release Synchrony and Oxford Economics Find Trust Will Define the Future of AI Shopping PR Newswire
FAQ

Questions about Synchrony Financial

What does Synchrony Financial do?
Synchrony Financial, together with its subsidiaries, operates as a consumer financial services company in the United States. It provides credit products such as credit cards, commercial credit products, and consumer installment loans. The company also offers private label credit cards, dual cards, co-brand and general purpose credit cards, short- and long-term installment loans, and consumer banking products; and deposit products, including certificates of deposit, individual retirement accounts, money market accounts, and savings accounts to retail and commercial customers, as well as accepts deposits through third-party securities brokerage firms.
What is SYF's market cap?
Synchrony Financial (SYF) is a listed stock with a live quote. The latest market cap on this page is $24B.
Where is Synchrony Financial headquartered?
Synchrony Financial is headquartered in Stamford, CT.
How do I get SYF news from the API?
Call GET /v1/news?tickers=SYF. Add type=news, type=press_release, or type=legal to take one feed. Pro keys search the full archive in real time. Free keys are delayed 15 minutes and return the last year. Signed-out visitors and Free accounts see that same year on this page. Pro sees the full archive.
How far back does SYF news go?
Signed-out visitors and Free accounts see the last year of stock news, press releases, and legal notices for SYF, 15 minutes behind, and each headline links to the publisher. Pro, including the 7-day trial, sees the full archive as headlines are ingested. A Free API key returns the last year. Pro keys search the full archive.
Is the SYF price on this page from the API?
The price and daily change update during the US session for every visitor. That quote is context on this page. It is not part of the news API. The chart is one candle per session from the start of 2020. 1W, 1M, and 1Y group those sessions.

Real-time stock news for $15 a month.

Start a 7-day Pro trial. A card is required. REST, WebSocket, and MCP are included, with 2,000 REST requests a day. Paid Pro removes the daily cap. If you don't subscribe, the account stays on Free.